Literature DB >> 23067021

FANCA and FANCG are the major Fanconi anemia genes in the Korean population.

J Park1, N-G Chung, H Chae, M Kim, S Lee, Y Kim, J-W Lee, B Cho, D C Jeong, I Y Park.   

Abstract

Fanconi anemia (FA) is a rare disorder characterized by physical abnormalities, bone marrow failure (BMF), increased risk of malignancies, and cellular hypersensitivity to DNA cross-linking agents. This study evaluated the genetic alterations in three major Fanconi genes (FANCA, FANCC, and FANCG) in 30 FA patients using multiplex ligation-dependent probe amplification and direct sequencing. Thirteen BMF patients were genetically classified as FA-A (n = 6, 46%) and FA-G (n = 7, 54%). Four common founder mutations were identified and included two FANCA mutations (c.2546delC and c.3720_3724delAAACA) and two FANCG mutations (c.307+1G>C and c.1066C>T), which had previously been commonly observed in a Japanese FA population. We also detected four novel deleterious mutations: c.2778+1G>C and c.3627-1G>A of FANCA, and c.1589_1591delATA and c.1761-1G>A of FANCG. This study shows that mutations in FANCA and FANCG are common in Korean FA patients and the existence of four common founder mutations in an East Asian FA population. Mutation screening workflow that includes these common mutations may be useful in the creation of an international database, and to better understand the ethnic characteristics of FA.
© 2012 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  FANCA; FANCG; Fanconi anemia; founding mutation; mutation analysis

Mesh:

Substances:

Year:  2013        PMID: 23067021     DOI: 10.1111/cge.12042

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  13 in total

Review 1.  Genetic counseling for Fanconi anemia: crosslinking disciplines.

Authors:  Heather A Zierhut; Rebecca Tryon; Erica M Sanborn
Journal:  J Genet Couns       Date:  2014-09-20       Impact factor: 2.537

2.  Clinical and Molecular Characterization of Fanconi Anemia Patients in Turkey.

Authors:  Güven Toksoy; Dilek Uludağ Alkaya; Gülendam Bagirova; Şahin Avcı; Agharza Aghayev; Nilay Günes; Umut Altunoğlu; Yasemin Alanay; Seher Başaran; Ezgi G Berkay; Birsen Karaman; Tiraje T Celkan; Hilmi Apak; Hülya Kayserili; Beyhan Tüysüz; Zehra O Uyguner
Journal:  Mol Syndromol       Date:  2020-09-23

Review 3.  Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.

Authors:  Che-Hong Chen; Julio Cesar Batista Ferreira; Eric R Gross; Daria Mochly-Rosen
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

Review 4.  Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair.

Authors:  Jasmine D Peake; Eishi Noguchi
Journal:  Hum Genet       Date:  2022-05-21       Impact factor: 5.881

Review 5.  Current insights into inherited bone marrow failure syndromes.

Authors:  Nack-Gyun Chung; Myungshin Kim
Journal:  Korean J Pediatr       Date:  2014-08-25

6.  Paternal or Maternal Uniparental Disomy of Chromosome 16 Resulting in Homozygosity of a Mutant Allele Causes Fanconi Anemia.

Authors:  Frank X Donovan; Danielle C Kimble; Yonghwan Kim; Francis P Lach; Ursula Harper; Aparna Kamat; MaryPat Jones; Erica M Sanborn; Rebecca Tryon; John E Wagner; Margaret L MacMillan; Elaine A Ostrander; Arleen D Auerbach; Agata Smogorzewska; Settara C Chandrasekharappa
Journal:  Hum Mutat       Date:  2016-02-23       Impact factor: 4.878

Review 7.  Update of the human and mouse Fanconi anemia genes.

Authors:  Hongbin Dong; Daniel W Nebert; Elspeth A Bruford; David C Thompson; Hans Joenje; Vasilis Vasiliou
Journal:  Hum Genomics       Date:  2015-11-24       Impact factor: 4.639

8.  Long-term follow-up of Fanconi anemia: clinical manifestation and treatment outcome.

Authors:  Byung Gyu Yoon; Hee Na Kim; Ui Joung Han; Hae In Jang; Dong Kyun Han; Hee Jo Baek; Tai Ju Hwang; Hoon Kook
Journal:  Korean J Pediatr       Date:  2014-03-31

9.  Understanding complexity of Fanconi anaemia.

Authors:  Dipika Mohanty
Journal:  Indian J Med Res       Date:  2016-02       Impact factor: 2.375

Review 10.  Could ALDH2*2 be the reason for low incidence and mortality of ovarian cancer for East Asia women?

Authors:  Shaomin Yan; Guang Wu
Journal:  Oncotarget       Date:  2017-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.